FDA approves another RSV option, this time it's Sanofi and AstraZeneca’s antibody drug for infants
The fight against one of the world’s most common respiratory viruses just got another weapon.
On Monday, the FDA approved Beyfortus, an antibody drug co …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
